Latest Patent Further Strengthens Intellectual Property Portfolio Covering Novel Platform for Precisely Controlling Core Cell Migration
MicroCures has entered into a material transfer agreement with the Henry M. Jackson Foundation for the Advancement of Military Medicine to conduct a preclinical study of siFi2 in animal models of spinal cord injury.
MicroCures announced the advancement of its ongoing collaborative research project with the United States Army Institute of Surgical Research (USAISR) in the area of burn wound healing.
MicroCures announced the issuance of a new Japanese patent providing broad protection for the company’s first-of-its-kind cell movement decelerator technology
MicroCures has been awarded a Phase 2 Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH).